151 related articles for article (PubMed ID: 27124944)
1. Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms.
Li H; Hasserjian RP; Kroft SH; Harrington AM; Wheaton SE; Pildain A; Ewalt MD; Gratzinger D; Hosking P; Olteanu H
Am J Clin Pathol; 2016 Apr; 145(4):538-51. PubMed ID: 27124944
[TBL] [Abstract][Full Text] [Related]
2. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification.
Liu W; Hasserjian RP; Hu Y; Zhang L; Miranda RN; Medeiros LJ; Wang SA
Mod Pathol; 2011 Mar; 24(3):375-83. PubMed ID: 21102413
[TBL] [Abstract][Full Text] [Related]
3. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
4. Acute leukaemia with a pure erythroid phenotype: under-recognized morphological and cytogenetic signatures associated universally with primary refractory disease and a dismal clinical outcome.
Park DC; Ozkaya N; Lovitch SB
Histopathology; 2017 Aug; 71(2):316-321. PubMed ID: 28261852
[TBL] [Abstract][Full Text] [Related]
5. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
[TBL] [Abstract][Full Text] [Related]
6. Pure Erythroid Leukemia Mimicking Ewing Sarcoma/Primitive Neuroectodermal Tumor in an Infant.
Lapadat R; Tower RL; Tam W; Orazi A; Gheorghe G
Pediatr Blood Cancer; 2016 May; 63(5):935-7. PubMed ID: 26773805
[TBL] [Abstract][Full Text] [Related]
7. Pure erythroid leukemia.
Wang W; Wang SA; Medeiros LJ; Khoury JD
Am J Hematol; 2017 Mar; 92(3):292-296. PubMed ID: 28006859
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
Hall J; Foucar K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
[TBL] [Abstract][Full Text] [Related]
9. How unique is pure erythroid leukaemia? A retrospective analysis of seven cases and review of the literature.
Wong E; Ling V; Westerman D; Morgan S; Juneja S
J Clin Pathol; 2015 Apr; 68(4):301-5. PubMed ID: 25609576
[TBL] [Abstract][Full Text] [Related]
10. Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group.
Chisholm KM; Heerema-McKenney AE; Choi JK; Smith J; Ries RE; Hirsch BA; Raimondi SC; Alonzo TA; Wang YC; Aplenc R; Sung L; Gamis AS; Meshinchi S; Kahwash SB
Blood Adv; 2020 Dec; 4(23):6000-6008. PubMed ID: 33284945
[TBL] [Abstract][Full Text] [Related]
11. Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia.
Wang HY; Huang LJ; Liu Z; Garcia R; Li S; Galliani CA
Hum Pathol; 2011 May; 42(5):749-58. PubMed ID: 21237494
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case.
Heiss S; Erdel M; Gunsilius E; Nachbaur D; Tzankov A
Hum Pathol; 2005 Oct; 36(10):1148-51. PubMed ID: 16226118
[TBL] [Abstract][Full Text] [Related]
13. Novel t(1;8)(p31.3;q21.3) NFIA-RUNX1T1 Translocation in an Infant Erythroblastic Sarcoma.
King RL; Siaghani PJ; Wong K; Edlefsen K; Shane L; Howard MT; Reichard KK; Mai M; Viswanatha DS; Greipp PT; Goble TA; Ruiz M; Hara H
Am J Clin Pathol; 2021 Jun; 156(1):129-138. PubMed ID: 33313700
[TBL] [Abstract][Full Text] [Related]
14. Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic/myeloproliferative neoplasms.
Kern W; Bacher U; Schnittger S; Alpermann T; Haferlach C; Haferlach T
Cytometry B Clin Cytom; 2013 May; 84(3):194-7. PubMed ID: 23283847
[TBL] [Abstract][Full Text] [Related]
15. Acute erythroid leukemia.
Zuo Z; Polski JM; Kasyan A; Medeiros LJ
Arch Pathol Lab Med; 2010 Sep; 134(9):1261-70. PubMed ID: 20807044
[TBL] [Abstract][Full Text] [Related]
16. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
Reddi DM; Lu CM; Fedoriw G; Liu YC; Wang FF; Ely S; Boswell EL; Louissaint A; Arcasoy MO; Goodman BK; Wang E
Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
[TBL] [Abstract][Full Text] [Related]
17. Acute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive Mimics: A Guide to a Number of Perplexing Entities.
Wang SA; Hasserjian RP
Am J Clin Pathol; 2015 Jul; 144(1):44-60. PubMed ID: 26071461
[TBL] [Abstract][Full Text] [Related]
18. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
19. The uniqueness of morphological features of pure erythroid leukemia in myeloid neoplasm with erythroid predominance: A reassessment using criteria revised in the 2016 World Health Organization classification.
Ko PS; Liu YC; Yeh CM; Gau JP; Yu YB; Hsiao LT; Tzeng CH; Chen PM; Chiou TJ; Liu CJ; Liu JH
PLoS One; 2017; 12(2):e0172029. PubMed ID: 28196090
[TBL] [Abstract][Full Text] [Related]
20. Pure erythroid leukemia evolving from a therapy-related myelodysplastic syndrome secondary to treatment for chronic lymphocytic leukemia.
Sadrzadeh H; Hasserjian R; Fathi AT
Am J Hematol; 2013 Mar; 88(3):240-1. PubMed ID: 22565525
[No Abstract] [Full Text] [Related]
[Next] [New Search]